Category: RSV Therapies
Promising Research Working Toward RSV Prevention
(Univ Colorado) As the number of hospitalizations related to respiratory syncytial virus (RSV) continues to climb steeply throughout Colorado, with a reported 1,139 hospitalizations since Oct. 1, clinician and researcher Eric Simões, MD, is leading two studies that he hopes will help curtail future RSV surges. Simões, a clinical professor of pediatric infectious diseases in the University of Colorado School of […]
Nov 28, 2022
Vaccines and drugs in the pipeline for RSV
(Reuters) There are no approved vaccines and only one drug in the United States for respiratory syncytial virus (RSV), a common respiratory virus that usually causes mild, cold-like symptoms but can also lead to serious illness and hospitalization. Sanofi and AstraZeneca drug nirsevimab recently became the second to get Europe’s approval to prevent RSV infections […]
Nov 21, 2022
A Surprising Finding Leads to an RSV Vaccine Breakthrough
(Bloomberg) While the world is still focused on fighting Covid, another nasty respiratory virus is on the march. It’s called RSV, which stands for respiratory syncytial virus, and it sends thousands of young children and elderly adults to the hospital every year. There isn’t yet a vaccine for RSV, but that could soon change. RSV shots from Pfizer and GSK have shown promising […]
Nov 18, 2022
What to know about RSV vaccine candidates and monoclonal antibodies
(The Hill) There are currently no vaccines for the surging virus and only one limited treatment option, but several products aiming to prevent severe disease are in development. RSV, which stands for respiratory syncytial virus, is surging in number of cases and hospitalizations in young patients across the country. RSV can cause severe clinical problems in infants, particularly […]
Nov 18, 2022
Soaring Infant Lung Illnesses Spur Race for Prevention
(Bloomberg) Doctors and parents are looking to new drugs and vaccines on the horizon to prevent a lung virus that’s been filling pediatric emergency rooms earlier than usual this season. Trial results this month from Pfizer Inc.’s maternal vaccine for respiratory syncytial virus, or RSV, and a European regulatory win for Sanofi and AstraZeneca Plc’s antibody that prevents the disease for a […]
Nov 15, 2022
Pfizer nabs RSV therapeutic biotech ReViral in quick $525M bolt-on
(Fierce Biotech) Pfizer has had plenty of success in respiratory syncytial virus (RSV) lately, with multiple FDA designations and clinical advancements for its vaccine candidate. But that’s not enough for the pharma giant. Today, the New York-based behemoth is acquiring ReViral and its collection of therapeutics for the pesky respiratory virus for $525 million.
Nov 15, 2022
RSV antibody from Sanofi and AstraZeneca approved in Europe
(Chemical and Engineering News) With the first vaccines to guard against respiratory syncytial virus (RSV) expected to receive regulatory approval in the months ahead, the European Commission earlier this month gave its nod to a monoclonal antibody developed by Sanofi and AstraZeneca to prevent RSV lower respiratory tract illness (LRTI) in newborns and infants. The […]
Nov 15, 2022
FDA Fast-Tracks Codagenix RSV Vaccine Candidate
(Contagion Live) Codagenix Inc. announced the US Food and Drug Administration (FDA) recently granted Fast Track designation to CodaVax-RSV, their respiratory syncytial virus (RSV) vaccine candidate. RSV is a common, contagious respiratory virus that attacks the lungs and breathing passageways. There is currently no approved vaccine for RSV, but an ongoing uptick in cases has led to an increased fervor of […]
Nov 7, 2022
EU Approves First Monoclonal Antibody To Prevent RSV In All Children As U.S. Cases Surge
(Forbes) The European Commission on Friday approved the first monoclonal antibody to prevent respiratory syncytial virus (RSV) among all infants and newborns, amid a rise of cases of the highly contagious virus, which can pose a danger to infants and older adults. The European Commission approved Beyfortus, an injection manufactured by AstraZeneca and Sanofi to […]
Nov 4, 2022
Why isn’t there an RSV vaccine for kids?
(NBC News) A failed clinical trial in the late ’60s pushed the development of an RSV vaccine back decades Cases of RSV continue to surge in the U.S., but a vaccine to protect young children against the respiratory virus remains a long ways off. RSV, or respiratory syncytial virus, is the most common cause of […]
Oct 27, 2022